drugset / Trial / NCT00863265

Phytosterols, Ezetimibe, and Cholesterol Metabolism

NCT00863265

RandomizedCrossoverQuadruple-blindBasic science

Summary

Phytosterols and ezetimibe each reduce intestinal cholesterol absorption by 30-55% but appear to have different mechanisms of action. The investigators' hypothesis is that phytosterols and ezetimibe given together will block cholesterol absorption in an additive fashion. In a randomized, placebo-controlled crossover trial the effects of placebo, ezetimibe treatment and ezetimibe plus phytosterol treatment will be measured.

Timeline

Start
2009-06
Primary completion
2009-10
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Ezetimibe Unknown 10 mg